Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Contraceptive agents help with menstrual issues, acne, and other health conditions in teens.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

Surgical and chemical castration have varied effects on heart and brain inflammation and artery function in sick rats.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Minoxidil sulfate affects Cl channels, while minoxidil affects K channels in cells.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Minoxidil effectively controls blood pressure in severe cases, but may cause fluid retention and edema.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.